Latest Insider Transactions at Prothena Corp Public LTD CO (PRTA)
This section provides a real-time view of insider transactions for Prothena Corp Public LTD CO (PRTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROTHENA CORP PUBLIC LTD CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROTHENA CORP PUBLIC LTD CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 24
2024
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$170,000
$34.0 P/Share
|
|
Jan 24
2024
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$65,000
$13.53 P/Share
|
|
Dec 20
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-66.78%
|
$185,000
$37.07 P/Share
|
|
Dec 20
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$65,000
$13.53 P/Share
|
|
Nov 30
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$170,000
$34.0 P/Share
|
|
Nov 30
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$65,000
$13.53 P/Share
|
|
Oct 25
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-75.54%
|
$205,000
$41.31 P/Share
|
|
Oct 25
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$65,000
$13.53 P/Share
|
|
Oct 11
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-94.45%
|
$188,000
$47.18 P/Share
|
|
Oct 11
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Oct 04
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-93.37%
|
$230,000
$46.9 P/Share
|
|
Oct 04
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Sep 27
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-95.96%
|
$235,000
$47.8 P/Share
|
|
Sep 27
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Sep 19
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$260,000
$52.36 P/Share
|
|
Sep 19
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Sep 13
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-98.58%
|
$220,000
$55.72 P/Share
|
|
Sep 13
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Sep 13
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$110,000
$55.48 P/Share
|
|
Sep 13
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$48,000
$24.9 P/Share
|
|
Sep 06
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-99.94%
|
$275,000
$55.01 P/Share
|
|
Sep 06
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Aug 30
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-81.97%
|
$275,000
$55.39 P/Share
|
|
Aug 30
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Aug 18
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$285,000
$57.18 P/Share
|
|
Aug 18
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Aug 16
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-77.68%
|
$236,000
$59.09 P/Share
|
|
Aug 16
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Aug 16
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-70.19%
|
$116,000
$58.94 P/Share
|
|
Aug 16
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$48,000
$24.9 P/Share
|
|
Aug 02
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-96.72%
|
$335,000
$67.45 P/Share
|
|
Aug 02
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Aug 02
2023
|
Wagner M. Zago Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-97.14%
|
$268,000
$67.53 P/Share
|
|
Aug 02
2023
|
Wagner M. Zago Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$48,000
$12.15 P/Share
|
|
Jul 26
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-74.99%
|
$310,000
$62.62 P/Share
|
|
Jul 26
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|
|
Jul 19
2023
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-89.66%
|
$345,000
$69.52 P/Share
|
|
Jul 19
2023
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$75,000
$15.04 P/Share
|
|
Jul 12
2023
|
Brandon S. Smith Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,000
-90.0%
|
$268,000
$67.67 P/Share
|
|
Jul 12
2023
|
Brandon S. Smith Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.12 P/Share
|
|
Jul 12
2023
|
Hideki Garren Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-97.7%
|
$134,000
$67.84 P/Share
|
|
Jul 12
2023
|
Hideki Garren Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$48,000
$24.9 P/Share
|
|
Jul 05
2023
|
Wagner M. Zago Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,000
-87.39%
|
$272,000
$68.34 P/Share
|
|
Jul 05
2023
|
Wagner M. Zago Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$48,000
$12.15 P/Share
|
|
Jul 05
2023
|
Carol D. Karp Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
5,000
-89.66%
|
$340,000
$68.34 P/Share
|
|
Jul 05
2023
|
Carol D. Karp Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.15 P/Share
|
|
Jul 03
2023
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
5,000
-63.73%
|
$335,000
$67.43 P/Share
|
|
Jul 03
2023
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+38.93%
|
$55,000
$11.33 P/Share
|
|
Jun 28
2023
|
Michael J Malecek Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-68.64%
|
$345,000
$69.93 P/Share
|
|
Jun 28
2023
|
Michael J Malecek Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$50,000
$10.27 P/Share
|